About

Gene Meta, genetic testing analysis platform of Ever Fortune AI, utilizes exclusive patented technology to analyze personal disease risks, physical characteristics, and drug efficacy across 851 items. It offers customized precision services for various industries, stepping into precision marketing and enhancing product competitiveness.
Ever Fortune AI is the only company in Asia that has successfully established a complete service chain as a provider of upstream and downstream genetic testing services. Through collaborations with medical center-level laboratories, it utilizes state-of-the-art microarray technology to achieve economies of scale among domestic and international users, ensuring that users can obtain the most cost-effective genetic testing services. With its innovative genetic data algorithms combined with large-scale medical databases, valuable genetic information is extracted from complex raw data. Ever Fortune AI has extensive experience in collaboration with precise service providers, allowing it to fully understand market demands and the future trends of its products in a timely manner. These advantages make Ever Fortune AI the sole choice in Asia for providing this innovative service model.